A vocal minority who are opposed to using tissue plasminogen activator (TPA) for treating strokes is contributing to fewer patients receiving the clot-busting drug, the New York Times reported.

Women 60 and older who take antibiotics for more than a couple of months have a higher risk of all-cause and cardiovascular death, according to research presented March 22 at the American Heart Association’s Epidemiology and Prevention/Lifestyle and Cardiometabolic Health scientific sessions.

St. Joseph Mercy Oakland in Pontiac, Michigan, is the first hospital certified by the Joint Commission as a thrombectomy-capable stroke center (TSC), according to a March 21 press release.

Increased exposure to air pollution may contribute to the higher risk of heart disease found in the black population, researchers reported in Arteriosclerosis, Thrombosis and Vascular Biology.

Surgical risk is an outdated measure of a patient’s eligibility for aortic valve replacement procedures, one Norfolk, Virginia, cardiologist said at the American College of Cardiology’s annual symposium last weekend—clinicians should instead be turning their attention to the idea of “TAVR suitability.”

Medtronic plc (NYSE: MDT) today announced new clinical data in interventional treatments for aortic and peripheral vascular diseases in a late-breaking trial session at Vascular Interventional Advances (VIVA) 2015.